Related Experiment Video
Updated: Jun 2, 2026

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
Activin and activin receptors in a rat osteogenic-sarcoma cell-line, umr-106
Abstract:
We have localized immunocytochemically activin-A-like reactivity in UMR-106 osteogenic cells with a characterized, specific antiserum against synthetic fragment of subunits of activin-A, a member of transforming growth factor B (TGFB) superfamily. No staining was seen when the activin BA-subunit antisera were replaced by immunoneutralized sera, antiserum dilution buffer, or normal rabbit serum. Using in situ hybridization and the reverse transcription polymerase chain reaction (RT-PCR), we have observed the expression of the BA-subunit of activin and activin receptors II & IIB, DNA sequencing data show that the RT-PCR product corresponds to the predicted fragments of activin-A and activin receptors, respectively. In addition, exogenously administered activin inhibited cell growth in cultured UMR-106 cells. Our findings have shown that (a) activin-A was localized immunohistochemically to UMR-106 cells, (b) expression of activin-A and its receptors are detected by in situ hybridization and RT-PCR in UMR-106 cells, and (c) activin may have an inhibitory autocrine function in the proliferation of these cells.
More Related Videos
06:00Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
09:37A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018